Literature DB >> 33692827

Macrophage M2 Co-expression Factors Correlate With the Immune Microenvironment and Predict Outcome of Renal Clear Cell Carcinoma.

Yutao Wang1, Kexin Yan2, Jiaxing Lin1, Jun Li1, Jianbin Bi1.   

Abstract

Purpose: In the tumor microenvironment, the functional differences among various tumor-associated macrophages (TAM) are not completely clear. Tumor-associated macrophages are thought to promote the progression of cancer. This article focuses on exploring M2 macrophage-related factors and behaviors of renal clear cell carcinoma. Method: We obtained renal clear cell carcinoma data from TCGA-KIRC-FPKM, GSE8050, GSE12606, GSE14762, and GSE3689. We used the "Cibersort" algorithm to calculate type M2 macrophage proportions among 22 types of immune cells. M2 macrophage-related co-expression module genes were selected using weighted gene co-expression network analysis (WGCNA). A renal clear cell carcinoma prognosis risk score was built based on M2 macrophage-related factors. The ROC curve and Kaplan-Meier analysis were performed to evacuate the risk score in various subgroups. The Pearson test was used to calculate correlations among M2 macrophage-related genes, clinical phenotype, immune phenotype, and tumor mutation burden (TMB). We measured differences in co-expression of genes at the protein level in clear renal cell carcinoma tissues.
Results: There were six M2 macrophage co-expressed genes (F13A1, FUCA1, SDCBP, VSIG4, HLA-E, TAP2) related to infiltration of M2 macrophages; these were enriched in neutrophil activation and involved in immune responses, antigen processing, and presentation of exogenous peptide antigen via MHC class I. M2-related factor frequencies were robust biomarkers for predicting the renal clear cell carcinoma patient clinical phenotype and immune microenvironment. The Cox regression model, built based on M2 macrophage-related factors, showed a close prognostic correlation (AUC = 0.78). The M2 macrophage-related prognosis model also performed well in various subgroups. Using western blotting, we found that VSIG4 protein expression levels were higher in clear renal cell carcinoma tissues than in normal tissues.
Conclusion: These co-expressed genes were most related to the M2 macrophage phenotype. They correlated with the immune microenvironment and predicted outcomes of renal clear cell carcinoma. These co-expressed genes and the biological processes associated with them might provide the basis for new strategies to intervene via chemotaxis of M2 macrophages.
Copyright © 2021 Wang, Yan, Lin, Li and Bi.

Entities:  

Keywords:  M2 macrophage; immune phenotype; risk model; tumor-associated macrophage; weighted gene co-expression network analysis

Year:  2021        PMID: 33692827      PMCID: PMC7938896          DOI: 10.3389/fgene.2021.615655

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  7 in total

1.  Losartan Blocks Osteosarcoma-Elicited Monocyte Recruitment, and Combined With the Kinase Inhibitor Toceranib, Exerts Significant Clinical Benefit in Canine Metastatic Osteosarcoma.

Authors:  Daniel P Regan; Lyndah Chow; Sunetra Das; Laurel Haines; Eric Palmer; Jade N Kurihara; Jonathan W Coy; Alissa Mathias; Douglas H Thamm; Daniel L Gustafson; Steven W Dow
Journal:  Clin Cancer Res       Date:  2022-02-15       Impact factor: 13.801

2.  Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With "Gray-Zone PSA" and Inhibits Cancer Progression via Regulating Glycosylation.

Authors:  Cong Zhang; Jikai Liu; Fan Chao; Shiyu Wang; Dawei Li; Dunsheng Han; Zhonghua Xu; Guoxiong Xu; Gang Chen
Journal:  Front Oncol       Date:  2021-11-22       Impact factor: 6.244

3.  Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphoma.

Authors:  Jose R Cortes; Ioan Filip; Robert Albero; Juan A Patiño-Galindo; S Aidan Quinn; Wen-Hsuan W Lin; Anouchka P Laurent; Bobby B Shih; Jessie A Brown; Anisha J Cooke; Adam Mackey; Jonah Einson; Sakellarios Zairis; Alfredo Rivas-Delgado; Maria Antonella Laginestra; Stefano Pileri; Elias Campo; Govind Bhagat; Adolfo A Ferrando; Raul Rabadan; Teresa Palomero
Journal:  Cell Rep       Date:  2022-04-19       Impact factor: 9.995

4.  Systematic Construction and Validation of a Novel Macrophage Differentiation-Associated Prognostic Model for Clear Cell Renal Cell Carcinoma.

Authors:  Chen Liu; Xuhui Zhang; Caoyang Hu; Xuezhi Liang; Xiaoming Cao; Dongwen Wang
Journal:  Front Genet       Date:  2022-06-14       Impact factor: 4.772

5.  Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease.

Authors:  Sang Youb Han; Jung Yeon Ghee; Jin Joo Cha; Young Sun Kang; Dae Young Hur; Han Seong Kim; Dae Ryong Cha
Journal:  Life (Basel)       Date:  2022-07-11

Review 6.  Dual role of fucosidase in cancers and its clinical potential.

Authors:  Jinxing Fu; Qing Guo; Yuan Feng; Peng Cheng; Anhua Wu
Journal:  J Cancer       Date:  2022-08-15       Impact factor: 4.478

7.  MND1 functions as a potential prognostic biomarker associated with cell cycle and immune infiltration in kidney renal clear cell carcinoma.

Authors:  Jiayu Fang; Jing Zhen; Yiyang Gong; Yun Ke; Bidong Fu; Yike Jiang; Jing Xie; Yue Liu; Yongqi Ding; Da Huang; Fan Xiao
Journal:  Aging (Albany NY)       Date:  2022-09-10       Impact factor: 5.955

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.